These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 27769056)

  • 1. Nuclear FOXO3 predicts adverse clinical outcome and promotes tumor angiogenesis in neuroblastoma.
    Hagenbuchner J; Rupp M; Salvador C; Meister B; Kiechl-Kohlendorfer U; Müller T; Geiger K; Sergi C; Obexer P; Ausserlechner MJ
    Oncotarget; 2016 Nov; 7(47):77591-77606. PubMed ID: 27769056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C10ORF10/DEPP-mediated ROS accumulation is a critical modulator of FOXO3-induced autophagy.
    Salcher S; Hermann M; Kiechl-Kohlendorfer U; Ausserlechner MJ; Obexer P
    Mol Cancer; 2017 May; 16(1):95. PubMed ID: 28545464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FOXO3-mediated chemo-protection in high-stage neuroblastoma depends on wild-type TP53 and SESN3.
    Rupp M; Hagenbuchner J; Rass B; Fiegl H; Kiechl-Kohlendorfer U; Obexer P; Ausserlechner MJ
    Oncogene; 2017 Nov; 36(44):6190-6203. PubMed ID: 28869600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FOXO3/FKHRL1 is activated by 5-aza-2-deoxycytidine and induces silenced caspase-8 in neuroblastoma.
    Geiger K; Hagenbuchner J; Rupp M; Fiegl H; Sergi C; Meister B; Kiechl-Kohlendorfer U; Müller T; Ausserlechner MJ; Obexer P
    Mol Biol Cell; 2012 Jun; 23(11):2226-34. PubMed ID: 22493319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Forkhead box O3 (FoxO3) regulates kidney tubular autophagy following urinary tract obstruction.
    Li L; Zviti R; Ha C; Wang ZV; Hill JA; Lin F
    J Biol Chem; 2017 Aug; 292(33):13774-13783. PubMed ID: 28705935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A drug library screen identifies Carbenoxolone as novel FOXO inhibitor that overcomes FOXO3-mediated chemoprotection in high-stage neuroblastoma.
    Salcher S; Spoden G; Hagenbuchner J; Führer S; Kaserer T; Tollinger M; Huber-Cantonati P; Gruber T; Schuster D; Gust R; Zwierzina H; Müller T; Kiechl-Kohlendorfer U; Ausserlechner MJ; Obexer P
    Oncogene; 2020 Jan; 39(5):1080-1097. PubMed ID: 31591479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The tubulin inhibitor MG-2477 induces autophagy-regulated cell death, ROS accumulation and activation of FOXO3 in neuroblastoma.
    Hagenbuchner J; Lungkofler L; Kiechl-Kohlendorfer U; Viola G; Ferlin MG; Ausserlechner MJ; Obexer P
    Oncotarget; 2017 May; 8(19):32009-32026. PubMed ID: 28415610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repaglinide Silences the FOXO3/Lumican Axis and Represses the Associated Metastatic Potential of Neuronal Cancer Cells.
    Salcher S; Spoden G; Huber JM; Golderer G; Lindner H; Ausserlechner MJ; Kiechl-Kohlendorfer U; Geiger K; Obexer P
    Cells; 2019 Dec; 9(1):. PubMed ID: 31861249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FOXO3-induced reactive oxygen species are regulated by BCL2L11 (Bim) and SESN3.
    Hagenbuchner J; Kuznetsov A; Hermann M; Hausott B; Obexer P; Ausserlechner MJ
    J Cell Sci; 2012 Mar; 125(Pt 5):1191-203. PubMed ID: 22349704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amplification-driven BCL6-suppressed cytostasis is mediated by transrepression of FOXO3 and post-translational modifications of FOXO3 in urinary bladder urothelial carcinoma.
    Wu WR; Lin JT; Pan CT; Chan TC; Liu CL; Wu WJ; Sheu JJ; Yeh BW; Huang SK; Jhung JY; Hsiao MS; Li CF; Shiue YL
    Theranostics; 2020; 10(2):707-724. PubMed ID: 31903146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FOXO3 is a latent tumor suppressor for FOXO3-positive and cytoplasmic-type gastric cancer cells.
    Tsuji T; Maeda Y; Kita K; Murakami K; Saya H; Takemura H; Inaki N; Oshima M; Oshima H
    Oncogene; 2021 Apr; 40(17):3072-3086. PubMed ID: 33795838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of Forkhead Box O3 Facilitates Inflammatory Colon Cancer: Transcriptome Profiling of the Immune Landscape and Novel Targets.
    Penrose HM; Cable C; Heller S; Ungerleider N; Nakhoul H; Baddoo M; Hartono AB; Lee SB; Burow ME; Flemington EF; Crawford SE; Savkovic SD
    Cell Mol Gastroenterol Hepatol; 2019; 7(2):391-408. PubMed ID: 30718226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SIRT3 promotion reduces resistance to cisplatin in lung cancer by modulating the FOXO3/CDT1 axis.
    Cao Y; Li P; Wang H; Li L; Li Q
    Cancer Med; 2021 Feb; 10(4):1394-1404. PubMed ID: 33655712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serine 574 phosphorylation alters transcriptional programming of FOXO3 by selectively enhancing apoptotic gene expression.
    Li Z; Zhao J; Tikhanovich I; Kuravi S; Helzberg J; Dorko K; Roberts B; Kumer S; Weinman SA
    Cell Death Differ; 2016 Apr; 23(4):583-95. PubMed ID: 26470730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological activation of FOXO3 suppresses triple-negative breast cancer in vitro and in vivo.
    Park SH; Chung YM; Ma J; Yang Q; Berek JS; Hu MC
    Oncotarget; 2016 Jul; 7(27):42110-42125. PubMed ID: 27283899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. C10ORF10/DEPP, a transcriptional target of FOXO3, regulates ROS-sensitivity in human neuroblastoma.
    Salcher S; Hagenbuchner J; Geiger K; Seiter MA; Rainer J; Kofler R; Hermann M; Kiechl-Kohlendorfer U; Ausserlechner MJ; Obexer P
    Mol Cancer; 2014 Sep; 13():224. PubMed ID: 25261981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin-like growth factor-I induces the phosphorylation and nuclear exclusion of forkhead transcription factors in human neuroblastoma cells.
    Schwab TS; Madison BB; Grauman AR; Feldman EL
    Apoptosis; 2005 Aug; 10(4):831-40. PubMed ID: 16133873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NEK6 dampens FOXO3 nuclear translocation to stabilize C-MYC and promotes subsequent de novo purine synthesis to support ovarian cancer chemoresistance.
    Liu J; Wang H; Wan H; Yang J; Gao L; Wang Z; Zhang X; Han W; Peng J; Yang L; Hong L
    Cell Death Dis; 2024 Sep; 15(9):661. PubMed ID: 39256367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The tumour suppressor FOXO3 is a key regulator of mantle cell lymphoma proliferation and survival.
    Obrador-Hevia A; Serra-Sitjar M; Rodríguez J; Villalonga P; Fernández de Mattos S
    Br J Haematol; 2012 Feb; 156(3):334-45. PubMed ID: 22107151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Forkhead box O3 promotes colon cancer proliferation and drug resistance by activating MDR1 expression.
    Gao Z; Li Z; Liu Y; Liu Z
    Mol Genet Genomic Med; 2019 Mar; 7(3):e554. PubMed ID: 30623608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.